S Kopf

Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial

S. Kahl, Sofiya Gancheva, Klaus Straßburger et al. · Diabetes Care · 2019 · 343 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Compromised DNA repair is responsible for diabetes‐associated fibrosis

Varun Kumar, Raman Agrawal, Aparamita Pandey et al. · The EMBO Journal · 2020 · 74 citations · Full text

Life Sciences, Molecular Biology, Pathobiology +17

The impact of a computerized physician order entry system implementation on 20 different criteria of medication documentation—a before-and-after study

Viktoria Jungreithmayr, Andreas D. Meid, Janina A. Bittmann et al. · BMC Medical Informatics and Decision Making · 2021 · 21 citations · Full text

Computing, Hospital Pharmacy, Pharmacy Practice +15

Elevated markers of DNA damage and senescence are associated with the progression of albuminuria and restrictive lung disease in patients with type 2 diabetes

Varun Kumar, Alba Sulaj, Manuel Blume et al. · EBioMedicine · 2023 · 17 citations · Full text

Medicine, Endocrinology, Pathology +17

Factor XII signaling via uPAR-integrin β1 axis promotes tubular senescence in diabetic kidney disease

Ahmed Elwakiel, Dheerendra Gupta, Rajiv Rana et al. · Nature Communications · 2024 · 16 citations · Full text

Life Sciences, Molecular Biology, Nephrology +17